← PHIBRO ANIMAL HEALTH CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $751.5m | $764.3m | $820.0m | $828.0m | $800.4m | $833.4m | $942.3m | $977.9m | $1.0b | $1.3b | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | $828.0m | — | — | — | — | — | — | |
| Cost of Revenue | $512.5m | $516.0m | $553.1m | $563.4m | $543.5m | $562.0m | $656.9m | $679.7m | $704.6m | $896.3m | |
| Cost of goods sold | — | — | $553.1m | $563.4m | $543.5m | $562.0m | $656.9m | $679.7m | $704.6m | ($896.3m) | |
| Gross Profit | $239.0m | $248.2m | $266.9m | $264.6m | $256.9m | $271.4m | $285.4m | $298.2m | $313.1m | $399.9m | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | $85.7m | $97.9m | $98.9m | $83.2m | $69.2m | $74.9m | $79.0m | $71.8m | $53.3m | $110.5m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $5.6m | $6.0m | $5.9m | $6.1m | $8.9m | $8.7m | $8.9m | $9.7m | $9.7m | $7.8m | |
| Capitalized Computer Software, Amortization | — | — | $1.5m | $1.2m | $1.0m | $1.3m | $1.0m | $1.5m | $1.4m | $1.4m | |
| Foreign Currency Transaction Gain (Loss), before Tax | $7.6m | $113k | $1.1m | $55k | ($826k) | $4.5m | $5.2m | ($2.5m) | ($23.9m) | ($7.9m) | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | — | $899k | $2.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $2.0m | $18.0m | $19.8m | $2.3m | ($3.1m) | $12.7m | $27.7m | $14.8m | ($22.8m) | $3.3m | |
| Interest and Other Income | ($256k) | $2.0m | $1.7m | $1.9m | $1.8m | $838k | $816k | $3.4m | $4.5m | $2.6m | |
| Other Operating Income | — | — | $98.9m | $1.5m | $69.2m | $74.9m | $79.0m | $71.8m | $53.3m | $110.5m | |
| Foreign currency losses, net | ($7.6m) | — | ($1.1m) | ($55k) | $826k | ($4.5m) | ($5.2m) | $2.5m | $23.9m | $7.9m | |
| Provision for income taxes | ($6.0m) | $15.9m | $23.2m | $16.8m | $22.0m | $12.1m | $23.2m | $21.5m | $8.5m | $19.7m | |
| basic (in shares) | 39.3m | 39.5m | $40k | $40k | $40k | $40k | $40.5m | $40.5m | $40.5m | $40.5m | |
| diluted (in shares) | 40.0m | 40.0m | $40k | $41k | $41k | $41k | $40.5m | $40.5m | $40.5m | $40.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $76.8m | $80.5m | $88.1m | $71.5m | $55.5m | $66.5m | $72.3m | $54.1m | $10.9m | $68.0m | |
| Income before income taxes | $76.8m | $80.5m | $88.1m | $71.5m | $55.5m | $66.5m | $72.3m | $54.1m | $10.9m | $68.0m | |
| Net Income (Loss) Attributable to Parent | $82.7m | $64.6m | $64.9m | $54.7m | $33.6m | $54.4m | $49.2m | $32.6m | $2.4m | $48.3m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $82.7m | $64.6m | $64.9m | $54.7m | $33.6m | $54.4m | $49.2m | $32.6m | $2.4m | $48.3m | |
| Earnings Per Share, Basic | $2.11 | $1.63 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | |
| Earnings Per Share, Diluted | $2.07 | $1.61 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | |
| Common Stock, Dividends, Per Share, Declared | $0.40 | $0.40 | $0.40 | $1.35 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | |
| Weighted Average Number of Shares Outstanding, Basic | 39.3m | 39.5m | 40k | 40k | 40k | 40k | 40.5m | 40.5m | 40.5m | 40.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 40.0m | 40.0m | 40k | 41k | 41k | 41k | 40.5m | 40.5m | 40.5m | 40.7m | |
| Research and Development Expense | $11.0m | $9.4m | $10.0m | $12.1m | $13.7m | $17.8m | $20.8m | $24.4m | $29.2m | $23.7m | |
| General and Administrative Expense | — | — | — | $38.5m | — | — | — | — | — | — | |
| Selling, General and Administrative Expense | $153.3m | $150.3m | $168.0m | $181.4m | $187.7m | $196.5m | $206.4m | $226.4m | $259.8m | $289.5m | |
| Selling, general and administrative expenses | $153.3m | $150.3m | $168.0m | $181.4m | $187.7m | $196.5m | $206.4m | $226.4m | $259.8m | $289.5m | |
| Business Combination, Acquisition Related Costs | $1.7m | $1.7m | $1.2m | $0 | — | — | — | — | — | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $23.0m | $37.2m | |
| Interest Expense | — | — | — | — | $14.6m | $13.7m | $12.7m | $18.7m | — | — | |
| Interest Expense, Debt | $16.8m | $16.9m | $13.6m | $13.7m | — | — | — | — | — | — | |
| Interest expense, net | — | — | $11.9m | $11.8m | $12.9m | $12.9m | $11.9m | $15.3m | $18.5m | $34.6m | |
| Current Income Tax Expense (Benefit) | $16.8m | $15.9m | $17.1m | $16.2m | $13.8m | $14.3m | $24.0m | $24.4m | $20.5m | $24.5m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | ($1.7m) | $0 | $0 | — | — | — | — | ($10.7m) | — | |
| Interest Income (Expense), Net | ($16.6m) | ($14.9m) | ($11.9m) | ($11.8m) | ($12.9m) | ($12.9m) | ($11.9m) | ($15.3m) | — | — | |
| Interest Income (Expense), Nonoperating, Net | $16.6m | $14.9m | ($11.9m) | $11.8m | ($12.9m) | ($12.9m) | ($11.9m) | ($15.3m) | ($18.5m) | ($34.6m) | |
| Income Tax Expense (Benefit) | ($6.0m) | $15.9m | $23.2m | $16.8m | $22.0m | $12.1m | $23.2m | $21.5m | $8.5m | $19.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.